Presentation1.pptxdilip shanghvi

10
DILIP SHANGHVI FOUNDER & MANAGING DIRECTOR OF SUN PHARMACEUTICALS Presented by Karan .K. Patel

Transcript of Presentation1.pptxdilip shanghvi

Page 1: Presentation1.pptxdilip shanghvi

DILIP SHANGHVIFOUNDER & MANAGING DIRECTOR OF SUN PHARMACEUTICALS

Presented by Karan .K. Patel

Page 2: Presentation1.pptxdilip shanghvi

EARLY LIFE AND EDUCATION :-

Born 1 October 1955 (age 60)Amreli, Gujarat, India

Residence Mumbai, MaharashtraNationality IndianEthnicity GujaratiAlma mater University of Calcutta (B.Com)Occupation Founder and MD of Sun Pharmaceuticals

Net worth

SpouseSon

US$ 18–19 billion

Vaibha D SanghviAalok D Sanghvi

Page 3: Presentation1.pptxdilip shanghvi

CAREER:-

• He started by helping his father in the latter's wholesale generic drugs business in Kolkata. It was during his work as a drugs distributor at Kolkata, he thought of manufacturing his own drugs instead of selling others' products.

• Dilip Shanghvi started Sun Pharmaceutical Industries with capital of Rs 10,000 in 1982 at Vapi

• Shanghvi founded Sun Pharmaceuticals in 1983 with five psychiatry products.

• Today, it is India's largest drugmaker and most valuable drug company.

• Appreciation of Sun's stock led to a 50% surge in his personal wealth, amounting to USD 4.7 billion.

• As of August 2014, he has a net worth of $17.2 billion, according to the Bloomberg Billionaire's Index.

• He has also been named in the list of Asia’s top ten wealthiest self-made billionaires, according to Wealth-X.

• Shanghvi is also the Chairman and Managing Director of Sun Pharma Advanced Research Company and Shantilal Shanghvi Foundation.

Page 4: Presentation1.pptxdilip shanghvi

COMPANY HISTORY:

Sun Pharma is a rising star of India's fast-growing pharmaceuticals industry.In less than a decade, Sun has lifted itself into fifth position in the country's pharmaceuticals market.

Sun manufactures a range of drugs for a range of medical specialties, treatments, and disorders.

Sun Pharma manufactures and markets its drugs through a number of subsidiaries and divisions, including Aztec, Inca, Sun, Milmet, Synergy, TDPL, Symbiosis, and Solares.

More than 70 percent of the company's sales come from within India.

Sun is also present in the United States, through Caraco Pharmaceutical Laboratories.

Page 5: Presentation1.pptxdilip shanghvi

JOURNEY :- 1982: Dilip S. Shanghvi launches Sun Pharmaceutical in Calcutta. 1983: With a loan of Rs 10,000, Sun Pharmaceutical begins

manufacturing drugs, then opens its manufacturing "shed" in Vapi. 1986: The company moves its administrative and corporate headquarters

to the West Coast and extends marketing coverage across India. 1987: The company unveils its cardiology products line. 1989: The company launches its another products line and begins export

operations.

1993: The SPARC research and development facility was started.

1994: The company goes public(IPO) on several Indian stock exchanges.

Page 6: Presentation1.pptxdilip shanghvi

ACQUISITIONS :-

1996: The company acquires Knoll Pharma's bulk actives division; it acquires stakes in Gujarat Lyka Organics Ltd.; a stake in MJ Pharma.

1997: TDPL was acquired and the company reorganizes into six operating divisions.

1998: The company acquires brands from Natco Pharma, including time-release technology.

2000: The company acquires the Pradeep Drug company, based in the Madras region.

2010: The company acquired 100% stake in Caraco pharmaceutical laboratories Ltd.

Also Acquired TARO Pharmaceuticals Industries Ltd

Page 7: Presentation1.pptxdilip shanghvi

In 2011 :- entered in joint venture with MSD with a focus emerging markets.

2012 :- The company acquired DVSA Pharmaceuticals, Inc

2013 :- The company acquired URL Pharma.

2014 :- Acquired Ranbaxy Laboratories Ltd at

US$ 4 billion. The landmark transaction was to create the world’s fifth largest speciality generic pharma company.

Page 8: Presentation1.pptxdilip shanghvi

AWARDS :- In 2005 :- Mr. Dilip Shanghvi is named Entrepreneur of

the Year (Healthcare and Life Science) 2007 :-1. First Generation Entrepreneur of the Year

CNBC-TV18, 2. Pharmaceutical Companies IMC Juran Quality Medal IMC Ramkrishna Bajaj National Quality Award Trust 2008 :-1. CEO of the Year by Business Standard 2. Entrepreneur of the Year Award by The Economic Times 2010 :- Mr. Dilip Shanghvi receives Entrepreneur of the Year Award by ERNST & YOUNG

Page 9: Presentation1.pptxdilip shanghvi

IN 2011 – 1.Mr. Dilip Shanghvi is honoured with Businessman of the Year Award Business India 2.Mr. Dilip Shanghvi is named Indian of the Year (Business) CNN IBN2014 -1. Entrepreneur of the Year Award by Forbes Magazine 2.Business Leader of the Year Award by The Economic Times 3.JRD TATA Corporate Leadership Award by All India Management Association

Page 10: Presentation1.pptxdilip shanghvi

Thank you